In Australia, Collagen Solutions PLC, which is registered in London and has global headquarters in Minnesota, received additional patent protection. The patent allows Collagen to source animal-based biomaterials from Australia for their pericardium tissue for heart valve replacements, orthopedics, dental industry, wound healing, surgery, and other medical uses. Australia and New Zealand are often sought-after by companies looking for high quality animal-based biomaterials because they have strict controls and have been doing it for a long time. Collagen’s CEO, Jamal Rushdy, told Proactive Investors UK, “This recent patent further strengthens our position in sourcing tissue in Australia in a novel way. We believe the additional processing covered in this patent will be of significant interest to our existing customer base.”
Latest article
Biobased sunglasses assist British special forces team with record-breaking Everest trek
In Nepal, four former British special forces soldiers were outfitted with bioplastic sunglasses from Teysha Technologies as they set a mountaineering record for traveling...
Diaper duty development: Hiro unveils nappy-eating fungi
In Texas, a startup has introduced a new diaper concept that aims to address one of the biggest challenges parents face: balancing sustainability with...
von Holzhausen creates “Ripple shoe” from proprietary renewable material
In California, sustainable material firm von Holzhausen has made a 100% biodegradable and plastic-free shoe from Liquidplant™, a polyurethane-like material developed in house out...